ALEC
Price
$1.17
Change
+$0.01 (+0.86%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
116.92M
6 days until earnings call
OABI
Price
$1.80
Change
-$0.05 (-2.70%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
223.51M
Ad is loading...

ALEC vs OABI

Header iconALEC vs OABI Comparison
Open Charts ALEC vs OABIBanner chart's image
Alector
Price$1.17
Change+$0.01 (+0.86%)
Volume$4.54K
Capitalization116.92M
OmniAb
Price$1.80
Change-$0.05 (-2.70%)
Volume$46.37K
Capitalization223.51M
ALEC vs OABI Comparison Chart
Loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ALEC vs. OABI commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALEC is a Buy and OABI is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (ALEC: $1.18 vs. OABI: $1.85)
Brand notoriety: ALEC and OABI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ALEC: 220% vs. OABI: 103%
Market capitalization -- ALEC: $116.92M vs. OABI: $223.51M
ALEC [@Biotechnology] is valued at $116.92M. OABI’s [@Biotechnology] market capitalization is $223.51M. The market cap for tickers in the [@Biotechnology] industry ranges from $275.91B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ALEC’s FA Score shows that 0 FA rating(s) are green whileOABI’s FA Score has 1 green FA rating(s).

  • ALEC’s FA Score: 0 green, 5 red.
  • OABI’s FA Score: 1 green, 4 red.
According to our system of comparison, OABI is a better buy in the long-term than ALEC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ALEC’s TA Score shows that 4 TA indicator(s) are bullish while OABI’s TA Score has 5 bullish TA indicator(s).

  • ALEC’s TA Score: 4 bullish, 4 bearish.
  • OABI’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, OABI is a better buy in the short-term than ALEC.

Price Growth

ALEC (@Biotechnology) experienced а +20.62% price change this week, while OABI (@Biotechnology) price change was +4.52% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

ALEC is expected to report earnings on Jul 31, 2025.

OABI is expected to report earnings on Mar 18, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OABI($224M) has a higher market cap than ALEC($117M). ALEC YTD gains are higher at: -37.566 vs. OABI (-47.740). OABI has higher annual earnings (EBITDA): -58.92M vs. ALEC (-136.16M). ALEC has more cash in the bank: 413M vs. OABI (59.4M). OABI has less debt than ALEC: OABI (23.8M) vs ALEC (42.5M). ALEC has higher revenues than OABI: ALEC (101M) vs OABI (20.4M).
ALECOABIALEC / OABI
Capitalization117M224M52%
EBITDA-136.16M-58.92M231%
Gain YTD-37.566-47.74079%
P/E RatioN/AN/A-
Revenue101M20.4M495%
Total Cash413M59.4M695%
Total Debt42.5M23.8M179%
FUNDAMENTALS RATINGS
ALEC: Fundamental Ratings
ALEC
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
94
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ALECOABI
RSI
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
50%
Momentum
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
49%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
79%
Bearish Trend 2 days ago
70%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
Advances
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 4 days ago
66%
Declines
ODDS (%)
Bearish Trend 8 days ago
87%
Bearish Trend 9 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
87%
Bullish Trend 2 days ago
68%
Aroon
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
85%
View a ticker or compare two or three
Ad is loading...
ALEC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OABI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RHHVF313.105.87
+1.91%
Roche Holding Ltd
ELUXY14.970.19
+1.29%
AB Electrolux
DNBBY25.070.12
+0.48%
DNB ASA
ANGPY6.16-0.26
-4.05%
Anglo American Platinum Ltd.
NUMIF0.03-0.01
-16.67%
Numinus Wellness Inc.

ALEC and

Correlation & Price change

A.I.dvisor indicates that over the last year, ALEC has been loosely correlated with RGNX. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if ALEC jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ALEC
1D Price
Change %
ALEC100%
+6.31%
RGNX - ALEC
48%
Loosely correlated
+13.43%
BEAM - ALEC
48%
Loosely correlated
+3.87%
DNLI - ALEC
47%
Loosely correlated
+1.85%
ABOS - ALEC
47%
Loosely correlated
+3.86%
RCKT - ALEC
45%
Loosely correlated
+2.44%
More

OABI and

Correlation & Price change

A.I.dvisor indicates that over the last year, OABI has been loosely correlated with TECH. These tickers have moved in lockstep 41% of the time. This A.I.-generated data suggests there is some statistical probability that if OABI jumps, then TECH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OABI
1D Price
Change %
OABI100%
+1.09%
TECH - OABI
41%
Loosely correlated
+2.20%
ALEC - OABI
39%
Loosely correlated
+6.31%
NTLA - OABI
37%
Loosely correlated
-2.65%
NAUT - OABI
37%
Loosely correlated
-5.10%
VCYT - OABI
37%
Loosely correlated
+1.08%
More